Biogen stock gains on leaked Alzheimer's drug data
December 08, 2016 at 16:52 PM EST
Biogen is scheduled to present early-stage data on aducanumab at a medical industry conference in San Diego on Friday, but an embargoed abstract of the presentation was leaked Thursday afternoon.